Combinations of urine-based tumour markers in bladder cancer surveillance

Can we still afford bladder cancer?

(2010) Arnulf Stenzl et al.   CURRENT OPINION IN UROLOGY

Nuclear Matrix Protein 22 as Adjunct to Urine Cytology and Cystoscopy in Follow-up of Superficial TCC of Urinary Bladder

(2009) Narmada P. Gupta et al.   UROLOGY

Economic aspects of bladder cancer: what are the benefits and costs?

(2009) K. D. Sievert et al.   WORLD JOURNAL OF UROLOGY

EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

(2008) Marko Babjuk et al.   EUROPEAN UROLOGY

Detection of tumours of the urinary tract in voided urine

(2008) Ellen C. Zwarthoff   SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY

Bladder Cancer: Chemoprevention, complementary approaches and budgetary considerations

(2008) H. Barton Grossman et al.   SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY

UroVysion FISH test for detecting urothelial cancers: Meta-analysis of diagnostic accuracy and comparison with urinary cytology testing

(2008) Tine Hajdinjak   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The Value of the UroVysion® Assay for Surveillance of Non–Muscle-Invasive Bladder Cancer

(2007) Sigurdur Gudjónsson et al.   EUROPEAN UROLOGY